- Home
- OVLY vs IKT Comparison
OVLY vs IKT Comparison
Compare OVLY & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVLY
- IKT
- Stock Information
- Founded
- OVLY 1990
- IKT 2008
- Country
- OVLY United States
- IKT United States
- Employees
- OVLY N/A
- IKT N/A
- Industry
- OVLY Major Banks
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- OVLY Finance
- IKT Health Care
- Exchange
- OVLY Nasdaq
- IKT Nasdaq
- Market Cap
- OVLY 201.8M
- IKT 168.0M
- IPO Year
- OVLY N/A
- IKT 2020
- Fundamental
- Price
- OVLY $25.44
- IKT $2.00
- Analyst Decision
- OVLY
- IKT Buy
- Analyst Count
- OVLY 0
- IKT 2
- Target Price
- OVLY N/A
- IKT $8.00
- AVG Volume (30 Days)
- OVLY 7.7K
- IKT 113.6K
- Earning Date
- OVLY 05-20-2025
- IKT 05-14-2025
- Dividend Yield
- OVLY 2.11%
- IKT N/A
- EPS Growth
- OVLY N/A
- IKT N/A
- EPS
- OVLY 2.97
- IKT N/A
- Revenue
- OVLY $78,869,000.00
- IKT N/A
- Revenue This Year
- OVLY N/A
- IKT N/A
- Revenue Next Year
- OVLY N/A
- IKT N/A
- P/E Ratio
- OVLY $8.47
- IKT N/A
- Revenue Growth
- OVLY 0.39
- IKT N/A
- 52 Week Low
- OVLY $22.70
- IKT $1.12
- 52 Week High
- OVLY $32.24
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- OVLY 53.17
- IKT 46.57
- Support Level
- OVLY $24.54
- IKT $1.78
- Resistance Level
- OVLY $25.90
- IKT $2.13
- Average True Range (ATR)
- OVLY 0.71
- IKT 0.16
- MACD
- OVLY 0.06
- IKT -0.01
- Stochastic Oscillator
- OVLY 64.06
- IKT 37.61
About OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.